T3011 oncolytic virus (OV) in patients with solid tumors

People with Metastatic Solid Tumors are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have disease progression after SOC therapy
  • Have adequate hepatic & renal function

You may NOT participate in this study if you:

  • Have prior treatment with another OV or cellular therapy
  • Have untreated and/or symptomatic metastatic central nervous system (CNS) disease
  • Have splenectomy, previous allogenic tissue/solid organ transplant
  • Have known immunodeficiency virus (HIV) infection, hepatitis B or C
  • Have live vaccines within 4 weeks of initiation of study treatment. (Seasonal flu or
  • SARS-CoV-2 vaccines that do not contain live viruses are permitted.)
  • Are pregnant or breastfeeding

Contact Information
Mohammad Ghalib, Research Manager
1695 Eastchester Road, 2nd floor
Bronx, NY 10461
Phone: (718) 405-8515
Email: mhghalib@montefiore.org